GENEVA, Aug. 21 -- ETHERNA IMMUNOTHERAPIES NV filed a patent application (EP2026/053884) for “MRNA COMBINATION FOR USE IN PREVENTING AND/OR TREATING AN AUTOIMMUNE DISEASE”. With publication no. WO/2026/171886, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 9/51
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....